Rebecca Haberman, MD, of NYU Langone Health, highlights precision medicine and potential prevention strategies, two areas of promising psoriatic arthritis research.
Rebecca Haberman, MD
Advertisement
Rebecca Haberman, MD, is a rheumatologist at NYU Langone Health specializing in psoriatic arthritis. She is also the associate director of the Psoriatic Arthritis Center at NYU Langone.
Articles by Rebecca Haberman, MD
Although her recent study acknowledges potential differences between White and non-White patients with psoriatic arthritis (PsA), Rebecca Haberman, MD, NYU Langone Health, emphasizes the need for further research to understand what these differences are and why they occur.
Recognizing psoriasis and psoriatic arthritis (PsA) in non-White patients is the first step toward providing more equitable care for those of all backgrounds with PsA, according to Rebecca Haberman, MD, of NYU Langone Health.
Although psoriatic arthritis may be more prevalent in White patients, Rebecca Haberman, MD, of NYU Langone Health, emphasizes that the disease affects those across diverse racial and ethnic backgrounds.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on AJMC
1
Physical Activity, Vaccination May Protect Against Long COVID
2
Real-World Data Show Preventive Nirsevimab Reduces Infant RSV Hospitalizations
3
In Its 50th Year, ESMO Comes to Berlin, a City Transformed
4
Medicare State Rankings Reveal Stark Differences in Access, Quality, and Affordability
5
